Catalog #BE0174FAB

InVivoMAb anti-mouse LAG-3 F(ab) fragment

Clone C9B7W f(ab) Fragments
Reactivities Mouse
Isotype Rat IgG1, κ

$560.00 - $7,581.50

$560.00 - $7.00

Choose an Option...
  • 25 mg - $7,581.50
  • 5 mg - $2,170.50
  • 1 mg - $560.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Description

This product is an F(ab) fragment derived from the anti-mouse LAG-3 antibody clone C9B7W. The C9B7W monoclonal antibody reacts with mouse LAG-3, also known as CD223, a 70 kDa type I transmembrane glycoprotein encoded by the Lag3 gene and belonging to the immunoglobulin superfamily. LAG-3 is expressed by activated T lymphocytes, NK cells, and regulatory T cells. Its primary ligand is MHC class II, which LAG-3 binds with higher affinity than CD4. LAG-3 is generally associated with immune checkpoint activity and has been reported to downregulate TCR signaling, inhibit CD4-dependent T cell function, and contribute to the suppressive function of regulatory T cells. In some contexts, LAG-3 has also been reported to promote immune responses through activation of antigen-presenting cells. Unlike a full-length antibody, this F(ab) fragment contains only the antigen-binding region and lacks the Fc domain. As a result, the fragment retains specific binding to mouse LAG-3 while eliminating Fc-mediated effector functions such as complement activation and Fcγ receptor engagement. Because the Fc region is absent, this format is useful in experiments where LAG-3 binding or receptor engagement is desired without Fc-dependent immune effects, including antibody-mediated cytotoxicity, Fcγ receptor–mediated cross-linking by accessory cells, or complement activation. The full-length C9B7W antibody has been reported to block the function of murine LAG-3 in vivo and in vitro, although studies suggest that this antibody does not block LAG-3 binding to MHC class II. The F(ab) fragment format may therefore provide a useful tool for studying LAG-3 biology, receptor engagement, and immune checkpoint signaling while minimizing secondary Fc-mediated mechanisms that can complicate interpretation of results. This anti-mouse LAG-3 F(ab) fragment is well suited for studies focused on LAG-3 targeting, checkpoint receptor engagement without Fc-mediated effects, and the functional role of LAG-3 in T cell, NK cell, and regulatory T cell biology.

Specifications

Isotype Rat IgG1, κ
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Immunogen Mouse CD223-Ig fusion protein
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤1EU/mg (≤0.001EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE and SEC
Sterility 0.2 µm filtration
Production Papain Digest
Purification Protein G
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product FAQs

Related Products

  1. Catalog #SIM0015
    InVivoSIM anti-human LAG-3 (Relatlimab Biosimilar) Read more
  2. Catalog #BP0174
    InVivoPlus anti-mouse LAG-3 Read more
  3. Catalog #BE0174
    InVivoMAb anti-mouse LAG-3 Read more
  4. Catalog #CP014
    RecombiMAb anti-mouse LAG-3 Read more
  5. Catalog #CP013
    RecombiMAb anti-mouse LAG-3 (D265A) Read more